| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Vaxcyte, Inc. | SVP, Finance & CAO | Common Stock | 31,362 | $1,943,816 | $61.98 | 02 Mar 2026 | Direct |
| Vaxcyte, Inc. | SVP, Finance & CAO | Stock Option (right to buy) | 98,568 | 26 Feb 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| PCVX | Vaxcyte, Inc. | 26 Feb 2026 | 6 | +$164,732 | 4 | SVP, Finance & CAO | 02 Mar 2026, 20:08 |
| PCVX | Vaxcyte, Inc. | 23 Dec 2025 | 3 | -$556,972 | 4 | SVP, FINANCE | 29 Dec 2025, 17:49 |
| PCVX | Vaxcyte, Inc. | 08 Sep 2025 | 1 | -$15,622 | 4 | SVP, FINANCE | 10 Sep 2025, 16:28 |
| PCVX | Vaxcyte, Inc. | 02 Sep 2025 | 2 | -$17,895 | 4 | SVP, FINANCE | 04 Sep 2025, 16:12 |
| PCVX | Vaxcyte, Inc. | 29 Aug 2025 | 2 | $0 | 4 | SVP, FINANCE | 29 Aug 2025, 20:08 |
| PCVX | Vaxcyte, Inc. | 27 Feb 2025 | 4 | -$41,103 | 4 | SVP, FINANCE | 03 Mar 2025, 21:16 |
| PCVX | Vaxcyte, Inc. | 16 Dec 2024 | 2 | +$199,999 | 4 | SVP, FINANCE | 18 Dec 2024, 16:13 |
| PCVX | Vaxcyte, Inc. | 07 Nov 2024 | 1 | $0 | 4 | SVP, FINANCE | 08 Nov 2024, 20:51 |
| PCVX | Vaxcyte, Inc. | 03 Sep 2024 | 4 | -$534,872 | 4 | SVP, FINANCE | 05 Sep 2024, 17:15 |
| PCVX | Vaxcyte, Inc. | 16 Jul 2024 | 3 | -$295,400 | 4 | SVP, FINANCE | 17 Jul 2024, 16:03 |
| PCVX | Vaxcyte, Inc. | 08 Jul 2024 | 3 | -$270,400 | 4 | SVP, FINANCE | 09 Jul 2024, 17:15 |
| PCVX | Vaxcyte, Inc. | 29 Feb 2024 | 8 | -$603,133 | 4 | SVP, FINANCE | 04 Mar 2024, 21:22 |
| PCVX | Vaxcyte, Inc. | 05 Sep 2023 | 1 | -$31,977 | 4 | SVP, Finance | 06 Sep 2023, 17:34 |
| PCVX | Vaxcyte, Inc. | 01 Mar 2023 | 2 | $0 | 4 | SVP, Finance | 03 Mar 2023, 16:11 |
| PCVX | Vaxcyte, Inc. | 01 Jan 2023 | 0 | $0 | 3 | SVP, Finance and Principal Accounting Officer | 04 Jan 2023, 15:33 |